Cheryl Arrowsmith, Chief Scientist of the Structural Genomics Consortium (SGC), Senior Scientist at the Princess Margaret Cancer Centre, and Professor at the Department of Medical Biophysics at the University of Toronto, has been recognized by UBC Medicine for her exceptional contributions to cancer research.

This recognition highlights Dr. Arrowsmith's significant work in structural biology and cancer therapy development. Her research has been pivotal in advancing our understanding of cancer mechanisms, particularly through identifying therapeutic targets and elucidating protein structures essential to cancer biology. 

Dr. Arrowsmith's contributions extend beyond her research publications. As the Chief Scientist of the SGC-Toronto, she leads an international open science program that collaborates closely with major pharmaceutical companies. This program is instrumental in developing and distributing unencumbered chemical probes, fostering an environment conducive to discovering new medicines.

UBC Medicine's acknowledgment of Dr. Arrowsmith's work reflects her influential role in driving forward cancer research on both national and international levels. 

We extend our heartfelt congratulations to Dr. Cheryl Arrowsmith on this well-deserved recognition.

For more information, read the full announcement here.